Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (131)
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.56
Total Value
$258.45K
Shares Held After
438,526
% of Holdings
4.2%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$40.97
Total Value
$819.40K
Shares Held After
2,231
% of Holdings
90.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.10
Total Value
$93.00K
Shares Held After
6,229,863
% of Holdings
0.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.10
Total Value
$124.00K
Shares Held After
906,556
% of Holdings
4.2%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
1,000
Price
$64.75
Total Value
$64.75K
Shares Held After
153,902
% of Holdings
0.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$65.21
Total Value
$228.23K
Shares Held After
153,902
% of Holdings
2.2%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
3,000
Price
$60.00
Total Value
$180.00K
Shares Held After
28,975
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
124
Price
$569.62
Total Value
$70.63K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
296
Price
$568.74
Total Value
$168.35K
Shares Held After
40,637
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
322
Price
$567.64
Total Value
$182.78K
Shares Held After
40,933
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
431
Price
$566.63
Total Value
$244.22K
Shares Held After
41,255
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,737
Price
$565.66
Total Value
$982.54K
Shares Held After
41,686
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,512
Price
$564.67
Total Value
$1.42M
Shares Held After
43,423
% of Holdings
5.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,449
Price
$563.47
Total Value
$816.46K
Shares Held After
45,935
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,069
Price
$562.35
Total Value
$601.16K
Shares Held After
47,384
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$561.67
Total Value
$202.20K
Shares Held After
48,453
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$560.36
Total Value
$291.38K
Shares Held After
48,813
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$559.21
Total Value
$204.11K
Shares Held After
49,333
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
276
Price
$558.32
Total Value
$154.10K
Shares Held After
49,698
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
39
Price
$556.89
Total Value
$21.72K
Shares Held After
49,974
% of Holdings
0.1%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF DEV. OFFICER
Shares
27,661
Price
$9.36
Total Value
$258.91K
Shares Held After
668,505
% of Holdings
4.0%
OmniAb, Inc. (OABI)
GUSTAFSON KURT A — Executive VP, Finance and CFO
Shares
6,913
Price
$1.49
Total Value
$10.30K
Shares Held After
261,483
% of Holdings
2.6%
OmniAb, Inc. (OABI)
Berkman Charles S — Chief Legal Officer
Shares
7,157
Price
$1.49
Total Value
$10.66K
Shares Held After
399,085
% of Holdings
1.8%
OmniAb, Inc. (OABI)
FOEHR MATTHEW W — Director
Shares
19,244
Price
$1.49
Total Value
$28.67K
Shares Held After
4,420,492
% of Holdings
0.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
1,030
Price
$22.20
Total Value
$22.87K
Shares Held After
27,865
% of Holdings
3.6%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
2,709
Price
$22.20
Total Value
$60.14K
Shares Held After
62,836
% of Holdings
4.1%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
40,000
Price
$2.03
Total Value
$81.20K
Shares Held After
203,797
% of Holdings
19.6%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
102,395
Price
$3.51
Total Value
$359.41K
Shares Held After
691,154
% of Holdings
12.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
83,332
Price
$14.41
Total Value
$1.20M
Shares Held After
2,217,781
% of Holdings
3.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.33
Total Value
$273.13K
Shares Held After
442,864
% of Holdings
4.1%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
2,653
Price
$20.45
Total Value
$54.25K
Shares Held After
1,122,626
% of Holdings
0.2%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
2,739
Price
$20.45
Total Value
$56.01K
Shares Held After
57,022
% of Holdings
4.6%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
853
Price
$20.45
Total Value
$17.44K
Shares Held After
31,705
% of Holdings
2.6%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
1,224
Price
$20.45
Total Value
$25.03K
Shares Held After
23,366
% of Holdings
5.0%
Zai Lab Ltd (ZLAB)
Smiley Joshua L — President and Chief Operating Officer
Shares
3,017
Price
$20.45
Total Value
$61.69K
Shares Held After
117,602
% of Holdings
2.5%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,443
Price
$69.75
Total Value
$100.65K
Shares Held After
105,212
% of Holdings
1.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
822
Price
$68.91
Total Value
$56.64K
Shares Held After
106,655
% of Holdings
0.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
7,278
Price
$50.01
Total Value
$363.97K
Shares Held After
0
% of Holdings
100.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Moat Ross — CHIEF OPERATING OFFICER
Shares
2,367
Price
$48.58
Total Value
$114.99K
Shares Held After
12,029
% of Holdings
16.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,434
Price
$164.01
Total Value
$235.19K
Shares Held After
301,185
% of Holdings
0.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
8,478
Price
$163.23
Total Value
$1.38M
Shares Held After
302,619
% of Holdings
2.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
787
Price
$161.73
Total Value
$127.28K
Shares Held After
311,097
% of Holdings
0.3%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
3,970
Price
$18.01
Total Value
$71.51K
Shares Held After
3,622
% of Holdings
52.3%
Nuvation Bio Inc. (NUVB)
Wentworth Kerry — CHIEF REGULATORY OFFICER
Shares
200,000
Price
$4.52
Total Value
$903.56K
Shares Held After
53,000
% of Holdings
79.1%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
100
Price
$105.60
Total Value
$10.56K
Shares Held After
324,879
% of Holdings
0.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
6,121
Price
$104.78
Total Value
$641.36K
Shares Held After
324,979
% of Holdings
1.8%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
12,425
Price
$103.78
Total Value
$1.29M
Shares Held After
331,100
% of Holdings
3.6%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
11,354
Price
$103.21
Total Value
$1.17M
Shares Held After
343,525
% of Holdings
3.2%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
6,901
Price
$50.00
Total Value
$345.05K
Shares Held After
12,546
% of Holdings
35.5%
Travere Therapeutics, Inc. (TVTX)
Baynes Roy D. — Director
Shares
10,000
Price
$33.00
Total Value
$330.00K
Shares Held After
37,500
% of Holdings
21.1%
Showing 51–100 of 131 transactions (page 2 of 3)